This systematic review and meta-analysis aims to evaluate the prognostic significance of BRAF, TERT, TP53, and PI3K pathway mutations in follicular-derived thyroid cancers to provide a more comprehensive understanding of their impact on clinical outcomes. This evidence concerns the gene TP53 and thyroid cancer.